JPWO2023198050A5 - - Google Patents
Info
- Publication number
- JPWO2023198050A5 JPWO2023198050A5 JP2024560502A JP2024560502A JPWO2023198050A5 JP WO2023198050 A5 JPWO2023198050 A5 JP WO2023198050A5 JP 2024560502 A JP2024560502 A JP 2024560502A JP 2024560502 A JP2024560502 A JP 2024560502A JP WO2023198050 A5 JPWO2023198050 A5 JP WO2023198050A5
- Authority
- JP
- Japan
- Prior art keywords
- adeno
- associated virus
- fusion
- peptide fragment
- capsid protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210383577.XA CN116925192B (zh) | 2022-04-12 | 2022-04-12 | 一种融合型腺相关病毒及其应用 |
| CN202210383577.X | 2022-04-12 | ||
| PCT/CN2023/087598 WO2023198050A1 (zh) | 2022-04-12 | 2023-04-11 | 一种融合型腺相关病毒及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025513072A JP2025513072A (ja) | 2025-04-22 |
| JP2025513072A5 JP2025513072A5 (https=) | 2026-03-23 |
| JPWO2023198050A5 true JPWO2023198050A5 (https=) | 2026-03-23 |
Family
ID=88328928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560502A Pending JP2025513072A (ja) | 2022-04-12 | 2023-04-11 | 融合型アデノ随伴ウイルスおよびその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250375535A1 (https=) |
| EP (1) | EP4509518A4 (https=) |
| JP (1) | JP2025513072A (https=) |
| CN (3) | CN116925192B (https=) |
| WO (1) | WO2023198050A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116925192B (zh) * | 2022-04-12 | 2025-04-29 | 合肥星眸生物科技有限公司 | 一种融合型腺相关病毒及其应用 |
| CN117801116A (zh) * | 2022-09-30 | 2024-04-02 | 上海玮美基因科技有限责任公司 | 一种融合型新型腺相关病毒及其应用 |
| WO2025254596A1 (en) * | 2024-06-06 | 2025-12-11 | Agency For Science, Technology And Research | Modified adeno-associated virus 1 (aav1) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8632764B2 (en) * | 2008-04-30 | 2014-01-21 | University Of North Carolina At Chapel Hill | Directed evolution and in vivo panning of virus vectors |
| HRP20171334T1 (hr) * | 2011-04-22 | 2017-11-17 | The Regents Of The University Of California | Virioni adeno-povezanog virusa s kapsid varijantom i postupci njihove upotrebe |
| WO2017161273A1 (en) * | 2016-03-18 | 2017-09-21 | The Children's Hospital Of Philadelphia | Therapeutic for treatment of diseases including the central nervous system |
| FI3445773T3 (fi) * | 2016-05-13 | 2023-03-30 | 4D Molecular Therapeutics Inc | Adenoassosioituneen viruksen kapsidimuunnoksia ja niiden käyttömenetelmiä |
| EP3775173A1 (en) * | 2018-04-05 | 2021-02-17 | Genethon | Hybrid recombinant adeno-associated virus serotype between aav9 and aavrh74 with reduced liver tropism |
| JP2022522995A (ja) * | 2019-01-18 | 2022-04-21 | ボイジャー セラピューティクス インコーポレイテッド | Ａａｖ粒子を生成するための方法及びシステム |
| CN110437317B (zh) * | 2019-01-30 | 2023-05-02 | 上海科技大学 | 具有变异衣壳蛋白的腺相关病毒及其用途 |
| EP4077684A1 (en) * | 2019-12-18 | 2022-10-26 | Genethon | Production of recombinant viral vectors from plant hairy roots |
| CN111349148A (zh) * | 2020-03-13 | 2020-06-30 | 辉大(上海)生物科技有限公司 | 一种腺相关病毒载体及其用途 |
| CN116209768A (zh) * | 2020-07-03 | 2023-06-02 | 吉尼松公司 | 用于通过高变区交换工程化新杂合aav衣壳的方法 |
| PL4211231T3 (pl) * | 2020-09-10 | 2024-11-04 | Genethon | Kapsyd AAV modyfikowany peptydem |
| CN112813037B (zh) * | 2021-01-08 | 2022-05-10 | 中国科学院动物研究所 | 一种高效感染原代小胶质细胞的重组突变腺相关病毒及其相关生物材料 |
| CN116925192B (zh) * | 2022-04-12 | 2025-04-29 | 合肥星眸生物科技有限公司 | 一种融合型腺相关病毒及其应用 |
-
2022
- 2022-04-12 CN CN202210383577.XA patent/CN116925192B/zh active Active
- 2022-04-12 CN CN202510763829.5A patent/CN120590489A/zh active Pending
-
2023
- 2023-04-11 JP JP2024560502A patent/JP2025513072A/ja active Pending
- 2023-04-11 US US18/856,580 patent/US20250375535A1/en active Pending
- 2023-04-11 CN CN202380033212.7A patent/CN119032100A/zh active Pending
- 2023-04-11 EP EP23786464.0A patent/EP4509518A4/en active Pending
- 2023-04-11 WO PCT/CN2023/087598 patent/WO2023198050A1/zh not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Drag et al. | Gene therapy for retinal degenerative diseases: progress, challenges, and future directions | |
| US12252470B2 (en) | Lipids and nanoparticle compositions thereof | |
| US20240299580A1 (en) | Apoe and apob modified lipid nanoparticle compositions and uses thereof | |
| US20220370357A1 (en) | Ionizable lipids and nanoparticle compositions thereof | |
| US20090011040A1 (en) | Use of compacted nucleic acid nanoparticles in non-viral treatments of ocular diseases | |
| JP7289306B2 (ja) | 網膜障害を治療するための組成物及び方法 | |
| US20240382432A1 (en) | Single chain variable fragment (scfv) modified lipid nanoparticle compositions and uses thereof | |
| CN114848850B (zh) | Rs1基因在制备xlrs治疗剂中的应用及治疗剂 | |
| EP4509518A1 (en) | Fusion type adeno-associated virus and use thereof | |
| JPWO2022076711A5 (https=) | ||
| US11845952B2 (en) | Adeno-associated virus vector | |
| JP2003522160A (ja) | 眼関連疾患の治療のための遺伝子治療 | |
| US20190201500A1 (en) | Compositions and methods of fas inhibition | |
| US20250352666A1 (en) | Lipid nanoparticle compositions and uses thereof | |
| WO2024066780A1 (zh) | 一种融合型新型腺相关病毒及其应用 | |
| WO2011017313A1 (en) | Method of administering non-viral nucleic acid vectors to the eye | |
| CA3239289A1 (en) | Functional aav capsids for intravitreal administration | |
| JPWO2023198050A5 (https=) | ||
| JP2021512912A (ja) | ウイルスベクター形質導入 | |
| JP7624727B2 (ja) | 合理的設計により増強された新規なａａｖウイルスによる網膜における高効率の形質導入および側方への広がり | |
| WO2025014832A1 (en) | Periocular delivery of aav vectors for treating ophthalmic pathologies | |
| CN115997012B (zh) | Rpe65相关眼睛疾病和障碍的治疗 | |
| CN120098093A (zh) | 一种融合型腺相关病毒及其应用 | |
| JPWO2021214282A5 (https=) | ||
| JPWO2021034418A5 (https=) |